Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACP3 | P15309 | 11/20 | 0.69 |
| ▸ | SRC | P12931 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | PGK1 | P00558 | 1/20 | 0.43 |
| ▸ | PGK2 | P07205 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL777805 | 0.92 | ACP3 (0.57) | ACP3SRCCA12MMP2PGK1 | |
| SCHEMBL232244 | 0.87 | ACP3 (0.79) | ACP3SRCPGK1PGK2 | |
| Hydrochloric Acid SCHEMBL1133241 | 0.85 | ACP3 (0.76) | ACP3SRC | |
| SCHEMBL776850 | 0.82 | ACP3 (0.51) | ACP3SRCALDH1A1GAACA12 | |
| SCHEMBL16859931 | 0.80 | ACP3 (0.71) | ACP3SRCCA12LMNA | |
| Phenol SCHEMBL4616870 | 0.79 | ACP3 (0.68) | ACP3SRCCA12PGK1PGK2 | |
| SCHEMBL777888 | 0.77 | ACP3 (0.64) | ACP3SRCGAAPGK1PGK2 | |
| SCHEMBL8158040 | 0.77 | ACP3 (0.65) | ACP3SRC | |
| SCHEMBL8158042 | 0.77 | ACP3 (0.65) | ACP3SRC | |
| SCHEMBL778799 | 0.76 | ACP3 (0.56) | ACP3CA12MMP2PGK1PGK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6630607-B2 | Electrophotography | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2003-10-07 | — | — | US | disclosed |
| US-20020147347-A1 | Aromatic methylidene compounds, aromatic aldehyde compounds and methylstyryl compounds used to prepare the methylidene compounds, and methods for preparing these compounds | MATSUSHITA ELECTIRC INDUSTRIAL CO., LTD. | 2002-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020147347-A1 | Aromatic methylidene compounds, aromatic aldehyde compounds and methylstyryl compounds used to prepare the methylidene compounds, and methods for preparing these compounds | MCCC2, RNF31, PRMT1 | ACP3 4674/4885SRC 2572/4885NPC1 1272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.